CHEMOKINE RECEPTOR BINDING COMPOUNDS

The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR4 or CCR5. In one aspect, these compounds demonstrate protectiv...

Full description

Saved in:
Bibliographic Details
Main Authors ZHOU, YUANXI, LI, TONG-SHUANG, METZ, MARKUS, BRIDGER, GARY J, BOURQUE, ELYSE, MCEACHERN, ERNEST J, SKERLJ, RENATO T, ZHU, YONGBAO, HARWING, CURTIS
Format Patent
LanguageEnglish
Spanish
Published 27.11.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to chemokine receptor binding compounds, pharmaceutical compositions and their use. More specifically, the present invention relates to modulators of chemokine receptor activity, preferably modulators of CCR4 or CCR5. In one aspect, these compounds demonstrate protective effects against infection of target cells by a human immunodeficiency virus (HIV). La presente invencion se refiere a compuestos de unión al receptor de quimiocina, a composiciones farmacéuticas y a su uso; más específicamente, la presente invención se refiere a moduladores de la actividad del receptor de quimiocina, preferiblemente moduladores de CCR4 o CCR5; en un aspecto, estos compuestos demuestran efectos protectores contra la infección de células de objetivo mediante un virus de inmunodeficiencia humana (VIH).
Bibliography:Application Number: MX20080002214